Vedolizumab: Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: case report

View at publisher Summarise with VIRAT
Cited by: 0
References: 1

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Cutaneous lymphoproliferative disorders research Drug-Induced Adverse Reactions Dermatology and Skin Diseases

Publication details

Journal / source
Reactions Weekly
Volume
2103
Issue
1
Pages
198–198
Publication date
26 March 2026
Language
EN